Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

HC Wainwright & Co. analyst Raghuram Selvaraju downgraded the rating for UroGen Pharma Ltd. ( URGN ) from Buy to Neutral. UroGen Pharma ( URGN ) shares closed at $4.17 on Wednesday. See how other analysts view this stock.

DA Davidson analyst Peter Heckmann downgraded Guidewire Software, Inc ( GWRE ). from Buy to Neutral and announced a $226 price target. Guidewire Software ( GWRE ) shares closed at $210.84 on Wednesday. See how other analysts view this stock.

Barclays analyst Lydia Rainforth downgraded the rating for Equinor ASA ( EQNR ) from Overweight to Equal-Weight. Equinor ( EQNR ) shares closed at $23.62 on Wednesday. See how other analysts view this stock.

Wedbush analyst Laura Chico downgraded Vigil Neuroscience, Inc. ( VIGL ) from Outperform to Neutral and lowered the price target from $13 to $8. Vigil Neuroscience ( VIGL ) shares closed at $2.31 on Wednesday. See how other analysts view this stock.

Citigroup analyst Patrick Donnelly downgraded Bruker Corporation ( BRKR ) from Buy to Neutral and cut the price target from $50 to $40. Bruker ( BRKR ) shares closed at $36.45 on Wednesday. See how other analysts view this stock.

Considering buying GWRE stock? Here’s what analysts think:

Read This Next:

Jim Cramer Recommends Not Buying Mosaic, Doesn’t Like This Industrial Stock

Photo via Shutterstock